URAC and 80 Organizations Call on DEA to Create Registry for Telemedicine Treatment of Substance Abuse

| URAC Staff
Digital Health Smart Icons

On Oct. 26th, URAC joined 80 other organizations, led by the Alliance for Connected Care, is calling for the U.S. Drug Enforcement Administration (DEA) to implement a telemedicine special registration. This registration process would enable providers to safely prescribe controlled substances remotely. 

The nation’s response to COVID-19 has demonstrated the value of increased access to telemedicine to enable all qualified providers, including Community Mental Health Centers and addiction treatment facilities, to prescribe Medication Assisted Treatment (MAT) to patients with Opioid Use Disorder (OUD).  

The failure to have a registry to allow for providers of telemedicine services to prescribe is a failure of the bureaucracy. On October 24, 2018, President Trump signed into law the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act. This legislation required the Attorney General, in consultation with the Secretary of Health and Human Services (HHS), to announce regulations specifying the circumstances for a special registration for telemedicine.  

It has been a full two years since adoption of the SUPPORT Act and no meaningful progress has been made to further the execution of this critical policy. 

Since the outset of the COVID-19 epidemic, the DEA, in partnership with the Substance Abuse and Mental Health Services Administration (SAMHSA), decided to allow remote prescribing of controlled substances using telemedicine without a prior in-person exam, regardless of the patient’s location. While this update is vital to ensuring patients continue to have access to the care they require, such an emergency action is only required because the DEA and other federal agencies have failed to execute the requirements of the SUPPORT Act.  

Given the worsening opioid overdose crisis, URAC and 80 stakeholder organizations urge the DEA to move forward with the telemedicine special registration process required by federal law that will enable SAMHSA waivered clinicians, Community Mental Health Centers and addiction treatment facilities to prescribe MAT to patients with OUD via telemedicine technology.  


Add new comment

Comment Policy
We welcome your comments to our blog articles. Comments not relevant to the posted topic, contain profanity, offensive or abusive language, or that attack a person individually, will be deleted. We reserve the right to delete any comments submitted to this blog without notice.
Your Information
These values will only be visible to admins. Only your name and the text of your comment will be displayed.
Your Comment

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Plain text

  • No HTML tags allowed.
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Enter the characters shown in the image.

Like this article?

We also recommend

Subscribe to The URAC Report